3860 — EPS Creative Health Technology Balance Sheet
0.000.00%
- HK$323.75m
- HK$236.58m
- HK$544.52m
- 34
- 56
- 48
- 42
Annual balance sheet for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 85.2 | 208 | 131 | 116 | 136 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 41.8 | 30.5 | 42.3 | 71.6 | 75.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 147 | 285 | 217 | 212 | 232 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.21 | 7.29 | 6.05 | 9.65 | 9.08 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 151 | 297 | 227 | 430 | 337 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.9 | 82.3 | 115 | 205 | 80.2 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 18 | 165 | 140 | 365 | 216 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 133 | 131 | 87.6 | 65.4 | 121 |
| Total Liabilities & Shareholders' Equity | 151 | 297 | 227 | 430 | 337 |
| Total Common Shares Outstanding |